Denosumab Protective Against Diabetes?
Med Page Today
FEBRUARY 13, 2024
(MedPage Today) -- Continued treatment with the osteoporosis drug denosumab (Prolia) was tied to a lower risk of developing diabetes in a Taiwanese cohort study. In a propensity score-matched analysis, adherence to denosumab for osteoporosis was.
Let's personalize your content